M C Weinstein. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisHumansLung Diseases, Obstructive/drug therapyLung Diseases, Obstructive/economicsLung Diseases, Obstructive/etiologyOrphan Drug Production/economicsUnited StatesValue of Lifealpha 1-Antitrypsin/therapeutic usealpha 1-Antitrypsin Deficiency
Substances: See more » alpha 1-Antitrypsin
Year: 1991 PMID: 1900676 PMCID: PMC1405048 DOI: 10.2105/ajph.81.4.414
Source DB: PubMed Journal: Am J Public Health ISSN: 0090-0036 Impact factor: 9.308